PI
WVE icon

PEAK6 Investments’s Wave Life Sciences WVE Stock Holding History

PEAK6 Investments’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$82K Hold
10,000
– – ﹤0.01% 3029
2024
Q2 		$49.9K Buy
+10,000
New +$57K ﹤0.01% 3162

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

PEAK6 Investments's WVE Position: Q3 2024 in Review

PEAK6 Investments held its Wave Life Sciences (WVE) position steady in Q3 2024 at 10,000 shares worth $82K. The position accounts for ﹤0.01% of the portfolio, ranked #3029.

PEAK6 Investments first reported a position in WVE in Q2 2024 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold WVE as of Q3 2024.

  • PEAK6 Investments held 10,000 shares of Wave Life Sciences worth $82K as of Q3 2024.
  • PEAK6 Investments left its Wave Life Sciences share count unchanged in Q3 2024.
  • Wave Life Sciences made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3029 holding.
  • PEAK6 Investments first reported a position in Wave Life Sciences in Q2 2024 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.